Citation Tools

Download PDFPDF

79 Tumor-immune signatures associated with response or resistance to tislelizumab (Anti-PD-1) in esophageal squamous cell carcinoma (ESCC)

Download to a citation manager

Cite this article as:
Xu J, Xu N, Bai Y, et al
79 Tumor-immune signatures associated with response or resistance to tislelizumab (Anti-PD-1) in esophageal squamous cell carcinoma (ESCC)